+44-1518-0811362025: Volume 9, Issue 1
Editorial P.1-2
Policy Gaps Fueling Antimicrobial Resistance Worldwide
Author(s):
David Acosta
DOI: 10.35841/AAVRJ-9.1.181
Editorial P.1-2
A Race Against Resistance: How Pharma is Responding
Author(s):
Emma Smith
DOI: 10.35841/AAVRJ-9.1.182
Editorial P.1-2
SVR and the Global Elimination Goals for Hepatitis C
Author(s):
Esther Siles
DOI: 10.35841/AAVRJ-9.1.183
Editorial P.1-2
Patient Journeys to SVR: Stories of Hope and Recovery
Author(s):
Luis Cereseto
DOI: 10.35841/AAVRJ-9.1.184
Editorial P.1-2
SVR and Reinfection Risk: What the Data Reveals
Author(s):
Byung Lee
DOI: 10.35841/AAVRJ-9.1.185
Editorial P.1-2
Communicating SVR Success: How Patients Interpret the News
Author(s):
Carol Konkle
DOI: 10.35841/AAVRJ-9.1.186
Editorial P.1-2
Drug Resistance in Tuberculosis: Time for New Strategies
Author(s):
Nicolas Robbings
Editorial P.1-2
AI in Antibiotic Development: Fighting Superbugs Smarter
Author(s):
Eun Chung
DOI: 10.35841/AAVRJ-9.1.189
Editorial P.1-2
WHO�s Role in Combatting the Drug Resistance Epidemic
Author(s):
Kae Collin
DOI: 10.35841/AAVRJ-9.1.190